PMID: 7544393Sep 1, 1995Paper

Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4

The Journal of Experimental Medicine
C A FargeasR P Sekaly

Abstract

The CD80 (B7-1) molecule is a 45-60-kD member of the immunoglobulin superfamily that is expressed on a variety of cell types of haematopoietic origin. CD80 can provide a critical costimulatory signal to T cells by interacting with the T cell surface molecule CD28. CD80 also binds to the CD28-related molecule CTLA4, which is expressed on activated T cells, Recently, additional ligands of CD28 and CTLA4 have been described in mice and humans. One of them, CD86 (B-70 or B7-2) was characterized at the molecular level. Although similar in predicted structure to CD80, it is distantly related in amino acid sequence. In this study, human CD80 mutants were generated and tested for their ability to maintain the interaction with CD28 leading to adhesion and enhanced IL-2 production. Two hydrophobic residues in the V-like domain of CD80 were identified as critical for binding to CD28 and are also important for the interaction with CTLA4. These residues are adjacent to the epitope of the BB1 antibody, which inhibits CD28-CD80 interactions. One of these residues, Y87, is conserved in all CD80 and CD86 cloned from various species. These results being to unravel the structural requirements for binding to CD28 and CTLA4.

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·Z Razi-WolfH Reiser
Oct 24, 1991·Nature·P C DriscollA F Williams
Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P S LinsleyJ A Ledbetter
Jan 1, 1988·Annual Review of Immunology·A F Williams, A N Barclay
Jul 16, 1987·Nature·J F BrunetP Golstein
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Nov 4, 1993·Nature·M AzumaC Somoza
Jan 1, 1993·Annual Review of Immunology·P S Linsley, J A Ledbetter

❮ Previous
Next ❯

Citations

Jun 22, 1999·Immunologic Research·J M SlavikB E Bierer
Mar 30, 2004·Biochemical and Biophysical Research Communications·Bruce Y MaAtsuo Ochi
Oct 1, 1996·Current Opinion in Neurobiology·T Brümmendorf, F G Rathjen
Apr 3, 2001·The Journal of Experimental Medicine·S Y TsengH Tsuchiya
Apr 7, 1997·The Journal of Experimental Medicine·Y WuY Liu
Jan 1, 2005·Veterinary Immunology and Immunopathology·Esteban A TerzoJosé M Pérez de la Lastra
Dec 6, 2003·Journal of Leukocyte Biology·Gérald J Prud'homme
Aug 27, 2019·Medicinal Research Reviews·Rui ChenKhaled Barakat
Dec 14, 2001·The Journal of Biological Chemistry·David V ErbeJames F Tobin
Jun 19, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yong-An ZhangJ Oriol Sunyer
Aug 9, 2002·The Journal of Biological Chemistry·Sasha LazeticJuha Punnonen
Sep 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kausik ChattopadhyayStanley G Nathenson
Jun 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S J FaasR P Rother
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael G AgadjanyanDavid B Weiner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.